Arizona State Retirement System Revance Therapeutics, Inc. Transaction History

Arizona State Retirement System

$15.6 Billion
Q3 2024

A detailed history of Arizona State Retirement System transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 28,572 shares of RVNC stock, worth $73,430. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,572

Previous 27,716 3.09%

Holding current value

$73,430

Previous $71,000 2.82%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$2.57 - $2.57 $2,199 - $2,199	856 Added 3.09%	28,572 $73,000
Q2 2024 Aug 05, 2024	BUY	$2.34 - $4.73 $14,030 - $28,361	5,996 Added 27.61%	27,716 $71,000
Q1 2024 May 07, 2024	SELL	$4.65 - $9.31 $7,616 - $15,249	-1,638 Reduced 7.01%	21,720 $106,000
Q4 2023 Jan 24, 2024	SELL	$5.81 - $11.2 $3,317 - $6,395	-571 Reduced 2.39%	23,358 $205,000
Q3 2023 Nov 06, 2023	BUY	$11.47 - $25.07 $4,324 - $9,451	377 Added 1.6%	23,929 $274,000
Q2 2023 Aug 01, 2023	SELL	$24.7 - $37.61 $7,088 - $10,794	-287 Reduced 1.2%	23,552 $596,000
Q1 2023 Apr 27, 2023	BUY	$18.36 - $35.27 $17,497 - $33,612	953 Added 4.16%	23,839 $767,000
Q4 2022 Feb 07, 2023	BUY	$18.32 - $30.66 $75,112 - $125,706	4,100 Added 21.82%	22,886 $422,000
Q3 2022 Nov 07, 2022	BUY	$14.33 - $28.47 $4,327 - $8,597	302 Added 1.63%	18,786 $507,000
Q2 2022 Jul 28, 2022	BUY	$11.52 - $20.4 $541 - $958	47 Added 0.25%	18,484 $255,000
Q1 2022 May 04, 2022	BUY	$12.36 - $20.31 $877 - $1,442	71 Added 0.39%	18,437 $360,000
Q4 2021 Feb 04, 2022	SELL	$12.46 - $27.87 $1,794 - $4,013	-144 Reduced 0.78%	18,366 $300,000
Q3 2021 Nov 12, 2021	BUY	$25.78 - $33.21 $2,010 - $2,590	78 Added 0.42%	18,510 $516,000
Q2 2021 Aug 02, 2021	BUY	$26.8 - $31.84 $26,719 - $31,744	997 Added 5.72%	18,432 $546,000
Q1 2021 May 06, 2021	BUY	$24.03 - $29.97 $5,478 - $6,833	228 Added 1.33%	17,435 $487,000
Q4 2020 Jan 28, 2021	BUY	$23.41 - $28.34 $40,101 - $48,546	1,713 Added 11.06%	17,207 $488,000
Q3 2020 Nov 05, 2020	BUY	$23.23 - $34.3 $91,293 - $134,799	3,930 Added 33.98%	15,494 $390,000
Q2 2020 Aug 04, 2020	BUY	$12.6 - $26.55 $8,316 - $17,523	660 Added 6.05%	11,564 $282,000
Q1 2020 May 05, 2020	BUY	$12.46 - $27.81 $135,863 - $303,240	10,904 New	10,904 $161,000

Others Institutions Holding RVNC

# of Institutions

234

Shares Held

82.8M

Call Options Held

680K

Put Options Held

896K

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.

Account

Arizona State Retirement System Revance Therapeutics, Inc. Transaction History